Emergent BioSolutions (EBS) EBT Growth (1y) (2012 - 2026)
Emergent BioSolutions (EBS) EBT Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -889.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -889.88% |
| Mar 31, 2026 | -85.54% |
| Dec 31, 2025 | -83.70% |
| Sep 30, 2025 | -59.55% |
| Jun 30, 2025 | 93.77% |
| Mar 31, 2025 | 666.12% |
| Dec 31, 2024 | 49.36% |
| Sep 30, 2024 | 153.55% |
| Jun 30, 2024 | -7.83% |
| Mar 31, 2024 | 107.53% |
| Dec 31, 2023 | 11.24% |
| Sep 30, 2023 | -295.68% |
| Jun 30, 2023 | -202.17% |
| Mar 31, 2023 | -4,126.32% |
| Dec 31, 2022 | -123.96% |
| Sep 30, 2022 | -47.69% |
| Jun 30, 2022 | -1,250.00% |
| Mar 31, 2022 | -104.46% |
| Dec 31, 2021 | -0.47% |
| Sep 30, 2021 | -182.73% |